Compare YALA & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YALA | PLSE |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2016 |
| Metric | YALA | PLSE |
|---|---|---|
| Price | $7.22 | $13.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | ★ 342.3K | 166.8K |
| Earning Date | 03-09-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.79 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $348,904,940.00 | $86,000.00 |
| Revenue This Year | $3.07 | N/A |
| Revenue Next Year | $11.99 | $1,002.94 |
| P/E Ratio | $8.81 | ★ N/A |
| Revenue Growth | ★ 5.80 | N/A |
| 52 Week Low | $3.83 | $12.56 |
| 52 Week High | $9.29 | $25.00 |
| Indicator | YALA | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 47.29 |
| Support Level | $6.46 | $13.82 |
| Resistance Level | $7.28 | $15.34 |
| Average True Range (ATR) | 0.23 | 0.77 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 80.95 | 16.89 |
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.